Daratumumab in Transfusion-Dependent Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Daratumumab in Transfusion-Dependent Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes
Am. J. Hematol 2021 Jan 15;[EPub Ahead of Print], G Garcia-Manero, M Diez-Campelo, E Vellenga, MA Jacoby, B Merchan, D Breems, A Cortelezzi, V Doronin, V Gomez, M Beckers, MGD Porta, H Varsos, L Xiu, N DeAngelis, I Nnane, E Rose, K van EygenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.